E16-Microbiologia Emergente y Traslacional
Epidemiología y Salud Pública / IBS-E16
Compuesto por investigadores del Servicio de Microbiología del Hospital Universitario Virgen de las Nieves y del Departamento de Microbiología de la Universidad de Granada. Cuenta además con un Investigador Contrato Monardes. La actividad se desarrolla en el Servicio de Microbiología del HU virgen de las Nieves, donde se ubica el Laboratorio de Referencia de Virus de Andalucía; en la Facultad de Medicina de la UGR y en Genyo.
Líneas de investigación
- Implicación de agentes infecciosos en enfermedades de etiología incierta
- Microorganismos multirresistentes
- Virus emergentes en patología humana
JAVIER RODRIGUEZ GRANGER
ANTONIO SAMPEDRO MARTINEZ
SARA LUISA SANBONMATSU GAMEZ
VICTORIA SANCHEZ MARTIN
Mª LUISA SERRANO GARCIA
CARMEN GABRIELA SORIA SEGARRA
ANA DEL CARMEN SORIANO LERMA
ANTONIO SORLOZANO PUERTO
FERNANDO COBO MARTINEZ
Mª GUADALUPE GARCIA MEDINA
JOSE ANTONIO GARCIA SALCEDO
JOSE GUTIERREZ FERNANDEZ
JOSE PATRICIO LINARES PALOMINO
ISAAC LOPEZ MACHADO
JOSE MARIA NAVARRO MARI
MATILDE ORTIZ GONZALEZ
IRENE PEDROSA CORRAL
MERCEDES PEREZ RUIZ
VIRGINIA PEREZ CARRASCO
MARIA ALBERTUZ CRESPO
Título: KIT, PROCEDIMIENTO Y APARATO DE ACONDICIONAMIENTO DE MUESTRAS BIOLOGICAS PARA ANALISIS CROMATOGRAFICO
Código: P201330112
Inventores: Rodríguez Maresca, Manuel ; Gutierrez Fernández, Jose
Título: Guía electrónica de resistencia Bacteriana
Código: GR-502-10
Alloscardovia omnicolens emerging presence in premature rupture of membranes
NEW MICROBIOLOGICA, 2019;
FI:1,593; Q4
Prevalence among males from the general population of agents responsible of not ulcerative genital tract infections, assisted in specialized care
REVISTA ESPANOLA DE QUIMIOTERAPIA, 2019;
FI:0,76; Q4
Male deep infections by Gardnerella vaginalis. A literature review and a case report
REVISTA ESPANOLA DE QUIMIOTERAPIA, 2019;
FI:0,76; Q4
Emergent genital infection by Leptotrichia trevisanii
INFECTION, 2019;
FI:2,927; Q2
Asymptomatic Leishmania infection in blood donors from the Southern of Spain
INFECTION, 2019;
FI:2,927; Q2
Inpatient candiduria: etiology, susceptibility to antifungal drugs and risk factors
REVISTA ESPANOLA DE QUIMIOTERAPIA, 2018;
FI:0,605; Q4
Cytomegalovirus Infection Monitoring Based on Interferon Gamma Release Assay in Kidney Transplantation
TRANSPLANTATION PROCEEDINGS, 2018;
FI:0,806; Q4
Osteoarticular tuberculosis of the hip and soft tissues: images of a diagnostic delay
REVISTA ESPANOLA DE QUIMIOTERAPIA, 2018;
FI:0,605; Q4
Urinary tract infection by Acinetobacter baumannii and Pseudomonas aeruginosa: evolution of antimicrobial resistance and therapeutic alternatives
JOURNAL OF MEDICAL MICROBIOLOGY, 2018;
FI:2,112; Q3
Nalidixic acid surrogate test for susceptibility to ciprofloxacin in Salmonella. Revisiting the question
JOURNAL OF MEDICAL MICROBIOLOGY, 2018;
FI:2,112; Q3
Safety and immunogenicity of the quadrivalent human papillomavirus (qHPV) vaccine in HIV-positive Spanish men who have sex with men (MSM)
AIDS RESEARCH AND THERAPY, 2017;
FI:1,605; Q4
Streptococcus agalactiae: prevention and vaccine development
REVISTA ESPANOLA DE QUIMIOTERAPIA, 2017;
FI:0,75; Q4
The first description of the extended-spectrum beta-lactamase bla(SHV-12) gene in a Salmonella monophasic Typhimurium strain isolated from acute gastroenteritis in a kidney transplant recipient in Southeast Spain
REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2017;
FI:1,401; Q4
Two Rare Cases of Wound Infections Caused by Trueperella bernardiae
JAPANESE JOURNAL OF INFECTIOUS DISEASES, 2017;
FI:1,273; Q4
Pleural effusion due to Parvimonas micra. A case report and a literature review of 30 cases
REVISTA ESPANOLA DE QUIMIOTERAPIA, 2017;
FI:0,75; Q4
Screening for Latent Tubertatiosts in the Patient with Moderate to Severe Psoriasis Who Is a Candidate for Systemic and/or Biotogic Therapy
ACTAS DERMO-SIFILIOGRAFICAS, 2016;
Preliminary evaluation of a new kit for differentiation of Mycobacterium tuberculosis complex species using Speed-Oligo MTBC
JOURNAL OF MEDICAL MICROBIOLOGY, 2016;
FI:2,269; Q3
Rapid diagnostic methods for acute viral respiratory infections
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2016;
FI:1,53; Q3
Multilocus Sequence Typing analysis of human Campylobacter coli in Granada (Spain)
REVISTA ESPANOLA DE QUIMIOTERAPIA, 2016;
FI:1,014; Q4
A new case report of urinary tract infection due to KPC-3-producing klebsiella pneumoniae (ST258) in Spain
ARCHIVOS ESPANOLES DE UROLOGIA, 2016;
FI:0,307; Q4
Characterization of daptomycin non-susceptible Enterococcus faecium producing urinary tract infection in a renal transplant recipient
REVISTA ESPANOLA DE QUIMIOTERAPIA, 2015;
FI:0,797; Q4
Chronic abdominal pain in Primary Care and presence of Helicobacter pylori and fecal parasites
REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2015;
FI:1,414; Q4
Detection of unusual uropathogens during a period of three years in a regional hospital
REVISTA ESPANOLA DE QUIMIOTERAPIA, 2015;
FI:0,797; Q4
Diagnosis of malaria in a regional hospital with assistance to immigrants and travellers
REVISTA ESPANOLA DE QUIMIOTERAPIA, 2015;
FI:0,797; Q4
Infectious aetiology of diarrhea studied in a tertiary hospital for a period of five years
REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2015;
FI:1,414; Q4
SAF2015-71714-R – RETOS I+D – JOSE A GARCIA SALCEDO – DESARROLLO DE UNA TERAPIA BASADA EN NANO-ANTICUERPOS FRENTE A VIRUS DE LA GRIPE
Financiador: MINISTERIO DE ECONOMIA Y COMPETITIVIDAD
Número de expediente: SAF2015-71714-R
Tiempo de ejecución: 01/01/2016 - 31/12/2018
IP: JOSE ANTONIO GARCIA SALCEDO
Nanosystems conjugated with antibody fragments for treating brain infections
Financiador: INSTITUTO DE SALUD CARLOS III
Número de expediente: AC18/00008
Tiempo de ejecución: 01/01/2019 - 31/12/2021
IP: JOSE ANTONIO GARCIA SALCEDO
RD16/0027/0012 – RICET – JOSE M NAVARRO
Financiador: INSTITUTO DE SALUD CARLOS III
Número de expediente: RD16/0027/0012
Tiempo de ejecución: 01/01/2017 - 31/12/2021
IP: JOSE MARIA NAVARRO MARI
3TR – Taxonomy, Treatment, Targets and Remission: Identification of the Molecular Mechanisms of non-response to Treatments, relapses and remission in Autoimmune Inflammatory Conditions
Financiador: Comisión Europea
Número de expediente: 3TR H2020 IMI2
Tiempo de ejecución: 01/09/2019 - 31/08/2026
IP: JOSE ANTONIO GARCIA SALCEDO
